• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD TRAY SPN WHIT25G3.5 L/B-D/E PLAST DRAPE; ANESTHESIA CONDUCTION KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD TRAY SPN WHIT25G3.5 L/B-D/E PLAST DRAPE; ANESTHESIA CONDUCTION KIT Back to Search Results
Model Number 405671
Device Problem Patient-Device Incompatibility (2682)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/09/2020
Event Type  malfunction  
Manufacturer Narrative
Medical device expiration date: unknown a sample is available for evaluation.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.
 
Event Description
It was reported that the bupivacaine/dextrose/marcaine were ineffective with a bd tray spn whit25g3.5 l/b-d/e plast drape.The following information was provided by the initial reporter: it was reported the bupivacaine/dextrose/marcaine medication mixture in the spinal trays has been ineffective.I was informed by anesthesia yesterday that they have been experiencing issues with the bupivicaine/dextrose/marcaine medication mixture in our spinal trays over the last few weeks.They thought at first that it was a fluke but this week alone, multiple providers have had the same issue and they have had at least 6 occurrences this week alone where the block did not work and they needed to go and grab a individual ampule from our med cart to perform the block.What was relayed to me is that the block was performed and medication injected and then the patient was still able to feel and could lift their leg.When they used a single ampule from our cart, it worked fine.
 
Event Description
It was reported that the bupivacaine/dextrose/marcaine were ineffective with a bd tray spn whit 25g3.5 l/b-d/e plast drape.The following information was provided by the initial reporter: it was reported the bupivacaine/dextrose/marcaine medication mixture in the spinal trays has been ineffective.I was informed by anesthesia yesterday that they have been experiencing issues with the bupivicaine/dextrose/marcaine medication mixture in our spinal trays over the last few weeks.They thought at first that it was a fluke but this week alone, multiple providers have had the same issue and they have had at least 6 occurrences this week alone where the block did not work and they needed to go and grab a individual ampule from our med cart to perform the block.What was relayed to me is that the block was performed and medication injected and then the patient was still able to feel and could lift their leg.When they used a single ampule from our cart, it worked fine.
 
Manufacturer Narrative
H.6.Investigation summary: three samples were received for evaluation.Two samples from lot 0001317747 and one sample from lot 0001283925 were provided.Failure mode could not be confirmed through sample analysis.Each vial was visually inspected for obvious defect.No obvious defects were observed.Liquid within each vial was clear and without any visible particulate matter.Over a period of more than 10 years, no test result from samples returned due to ineffective anesthesia has ever failed to meet specifications.The causes of ineffective anesthesia have been well documented in clinical literature for many years.Whereas a strong history of testing has supported that drug potency is not the cause, the actual cause may not always be ascertained.Bd has a long history of test results to support that drug potency issues have not been the cause of ineffective anesthesia events reported to bd through the complaint system.As a preventive action, the vendor of the applicable drug component (hospira / pfizer) will be notified of the reported failure mode from the customer.Likewise, the complaint will be entered into the complaint management system and will be tracked & trended for future occurrences and reviewed/investigated through the quality data analysis (qda) process if an adverse trend is identified.No lot was reported however, a device history record review was performed on each of the sample lots that were returned to (b)(6).Dhr review results offers no objective evidence that could be correlated to the reported complaint failure mode.H3 other text : see section h.10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD TRAY SPN WHIT25G3.5 L/B-D/E PLAST DRAPE
Type of Device
ANESTHESIA CONDUCTION KIT
MDR Report Key9647860
MDR Text Key202232930
Report Number1625685-2020-00011
Device Sequence Number1
Product Code CAZ
UDI-Device Identifier00382904056711
UDI-Public00382904056711
Combination Product (y/n)N
PMA/PMN Number
DISCRETION
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 04/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/30/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number405671
Device Catalogue Number405671
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/24/2020
Date Manufacturer Received01/09/2020
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-